New Delhi: Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for “failed degradation specifications”, ...
Read moreNew Delhi: The 30-scrip Sensitive Index (Sensex) and broader 50-scrip Nifty at National Stock Exchange (NSE) traded range bound with positive ...
Read moreMumbai: India has done a tremendous job on the vaccination drive but it will take at least nine more months ...
Read moreBengaluru: Biocon chairperson Kiran Mazumdar-Shaw Monday night said she tested COVID-19 positive. "I have added to the COVID-19 count by ...
Read moreBengaluru: India needs to draw up its immunisation strategy now itself on the administration of vaccine for COVID-19 on the ...
Read moreIndia’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for “restricted emergency use” to treat ...
Read moreNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreIndustrialist Rahul Bajaj opined at an event organised by Economic Times recently that the government appeared to be unwilling to ...
Read moreBengaluru: The European Commission (EC) has approved the cancer cure drug Ogivri that Biocon co-developed with its US-based partner Mylan, ...
Read more
It goes to the credit of Indian voters that they could realise absolute power has chances to turn a single...
Read more
In what can be seen as an ominous development for India, a cargo ship from Pakistan recently docked at the...
Read more
Sri Lanka is in the grip of a political tsunami with the coalition of National People’s Power (NPP), led by...
Read more
If I have a dispute with you, I can solve it in one of three ways. One is by talking...
Read more
